Veeva Systems Inc (VEEV) Stock Price & Analysis
Veeva Systems Inc (VEEV) rose 0.26% to USD 167.68 as of June 9, 2026 at 23:35 UTC, according to Nexqual real-time market data.
VEEV last closed at USD 167.24; the session ranged USD 165.11–172.39 on volume of 2,010,857 shares. Market capitalization is $27.24B, with a 52-week range of USD 148.05–310.5 (NYQ). Source: Nexqual, June 9, 2026 at 23:35 UTC.
Key Statistics (as of June 9, 2026 at 23:35 UTC)
| Price | USD 167.68 |
|---|---|
| Change | ▲ 0.26% (up) |
| Previous Close | USD 167.24 |
| Open | USD 165.51 |
| Day Range | USD 165.11 – 172.39 |
| 52-Week Range | USD 148.05 – 310.5 |
| Volume | 2,010,857 shares |
| Market Cap | $27.24B |
| Exchange | NYQ |
Technical Analysis (VEEV)
Nexqual's technical model rates VEEV "NEUTRAL" based on 3 bullish and 2 bearish signals across 124 daily candles, as of June 9, 2026 at 23:35 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 49.78 (neutral) |
| vs SMA50 | Above (USD 165.98) |
| MACD | 2.2 (positive) |
Analyst Ratings (VEEV)
Wall Street analysts rate VEEV "Buy" based on 28 analysts, with a mean price target of USD 248.29 (range USD 165–350), per Nexqual as of June 9, 2026 at 23:35 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 28 |
| Mean Target | USD 248.29 |
| High Target | USD 350 |
| Low Target | USD 165 |
| Buy / Hold / Sell | 22 / 7 / 1 |
Earnings (VEEV)
| Next Earnings Date | 2026-09-02 |
|---|---|
| EPS Estimate | USD 2.22 |
| Revenue Estimate | $905.27M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-04-30 | USD 2.24 vs est 2.14 ▲ beat |
| 2026-01-31 | USD 2.06 vs est 1.94 ▲ beat |
| 2025-10-31 | USD 2.04 vs est 1.95 ▲ beat |
| 2025-07-31 | USD 1.99 vs est 1.9 ▲ beat |
Source: Nexqual, June 9, 2026 at 23:35 UTC.
Financials & Fundamentals (VEEV)
| Total Revenue | $3.32B |
|---|---|
| Revenue Growth (YoY) | +16.30% |
| Gross Margin | +75.02% |
| Operating Margin | +30.93% |
| Profit Margin | +28.37% |
| ROE | +13.93% |
| Debt / Equity | 1.41 |
| Current Ratio | 4.74 |
| Total Cash | $7.31B |
| Total Debt | $103.07M |
| Free Cash Flow | $1.26B |
Source: Nexqual, June 9, 2026 at 23:35 UTC.
Financial Health Score (VEEV)
Nexqual rates Veeva Systems Inc's overall financial health "Strong" across five dimensions, as of June 9, 2026 at 23:35 UTC.
| Growth | Strong — Revenue +16% YoY (annual) |
|---|---|
| Profitability | Strong — Gross margin 75%, operating 31% |
| Balance Sheet | Strong — $7.31B cash vs $103M debt, net cash position |
| Cash Flow | Strong — FCF $1.26B, 39% margin |
| Efficiency | Mixed — ROE 14%, ROA 7.3% |
Ownership (VEEV)
| Insider Ownership | +8.58% |
|---|---|
| Institutional Ownership | +89.27% |
| Shares Outstanding | 162.44M |
| Float | 148.97M |
| Short % of Float | +6.94% |
Source: Nexqual, June 9, 2026 at 23:35 UTC.
Leadership (VEEV)
Veeva Systems Inc is led by Peter P. Gassner (age 60), Founder, CEO & Director, per Nexqual as of June 9, 2026 at 23:35 UTC.
| Founder, CEO & Director | Peter P. Gassner (age 60) |
|---|---|
| President & Chief of Staff | Eleni Nitsa Zuppas (age 55) |
| President & Chief Customer Officer | Thomas D. Schwenger (age 57) |
| Chief Financial Officer | Brian Van Wagener (age 42) |
| Director of Investor Relations | Gunnar Georg Hansen |
Major Backers & Investors (VEEV)
Notable institutional backers of Veeva Systems Inc include Alliancebernstein L.P., T. Rowe Price, Linonia Partnership LP, according to Nexqual as of June 9, 2026 at 23:35 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Alliancebernstein L.P. | 3.86% |
| T. Rowe Price | 3.09% |
| Linonia Partnership LP | 3.03% |
| Principal Financial Group, Inc. | 2.55% |
| FMR, LLC | 1.61% |
| Principal Funds, Inc-MidCap Fund | 1.58% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 16.37% |
| BlackRock | 7.12% |
| State Street | 2.22% |
| Geode Capital | 2.04% |
Source: Nexqual, June 9, 2026 at 23:35 UTC.
From Veeva Systems Inc's Latest SEC 10-K Filing (filed 2026-03-20)
Key Strengths & Strategy (as disclosed to the SEC)
- Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America.
- The company offers Veeva Commercial Cloud comprising Veeva Vault CRM Suite for pharmaceutical and biotechnology companies; Veeva Medical that provides source of medical content across multiple channels and geographies; Veeva PromoMats, an end-to-end content and digital asset management solution; and Veeva Crossix, an analytics platform for pharmaceutical brands.
- It also provides Veeva Data Cloud, such as Veeva OpenData, a customer reference data solution; Veeva Link, which provides deep data; Veeva Compass, which includes de-identified and longitudinal patient data; and Veeva CRM Pulse that provides access and multichannel engagement metrics.
- In addition, the company offers Veeva Development Cloud consisting of Veeva Clinical Platform, which advances clinical trial execution; Veeva Clinical Data Management that helps sponsors and CROs design and run trials; Veeva Safety, which unifies systems and processes; Veeva RIM that provides regulatory information management capabilities, as well as Veeva Quality Cloud, which is used by the life sciences and consumer products industries; and Veeva Business Consulting services.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| TEAM | Atlassian Corporation | USD 95.61 | ▼ 3.88% |
| OKTA | Okta, Inc. | USD 119.96 | ▲ 1.04% |
| PAYC | Paycom Software, Inc. | USD 136.14 | ▼ 1.08% |
| WDAY | Workday, Inc. | USD 140.23 | ▼ 2.81% |
| TWLO | Twilio Inc. | USD 204.69 | ▼ 9.43% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 9, 2026 at 23:35 UTC. This page is informational and not investment advice.